ESR1 and cancer: Enriched pathways for upregulated miRNAs included: “Chemical carcinogenesis–receptor activation” (p-value = 0.018) associated with ESR1, FGF18, JAG1, KPNA6, PPARA genes; the pathway “Proteoglycans in cancer” (p-value = 0.089) associated with genes ESR1, FRS2, HIF1A, PDCD4.